Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, New York.
Department of Surgery, Columbia University College of Physicians and Surgeons/NewYork-Presbyterian Hospital, New York, New York.
Ann Thorac Surg. 2018 Feb;105(2):528-534. doi: 10.1016/j.athoracsur.2017.07.019. Epub 2017 Nov 23.
Transporting patients receiving extracorporeal membrane oxygenation (ECMO) support is safe and reliable with a dedicated program and established management protocols. As our program has grown, our teams have had to adapt to manage surges in transport volume while maintaining patient safety. We assessed the outcomes at peak use of our ECMO transport services during surges.
We conducted a single-center retrospective review of all patients transported to our institution while supported with ECMO from September 2008 to September 2016. Survival to discharge was the primary outcome. Surge patients were defined as those transported during months with at least 8 transports or patients transported within 24 hours of another patient in nonsurge months.
From 2008 to 2016, 222 patients were transported to our institution while supported with ECMO. Baseline characteristics and indices of disease severity were comparable between surge and nonsurge patients. Of the 84 patients transported during surges, 59 surge patients (70%) survived to hospital discharge vs 86 (63%) of nonsurge patients (p = 0.31). Multivariable logistic regression showed that age and APACHE II (Acute Physiology and Chronic Health Evaluation) severity index score were predictors of in-hospital death (p < 0.05), but transportation during a surge was not (odds ratio, 0.91; 95% confidence interval, 0.46 to 1.80; p = 0.79).
Patient safety and clinical outcomes can be maintained during surges in ECMO transport volume if the ECMO program has developed plans for handling transient increases in volume and considers staff fatigue and burnout. Standardizing interhospital communication, patient selection, and management protocols are critical to maintaining quality of care.
通过专门的项目和既定的管理方案,转运接受体外膜肺氧合(ECMO)支持的患者是安全可靠的。随着我们项目的发展,我们的团队必须适应管理转运量的激增,同时保持患者安全。我们评估了在 ECMO 转运服务高峰期使用时的结果。
我们对 2008 年 9 月至 2016 年 9 月期间我院所有接受 ECMO 支持转运的患者进行了单中心回顾性研究。主要结局为出院存活率。转运高峰患者定义为至少 8 例患者转运的月份或非转运高峰月份内 24 小时内转运另一名患者的月份。
2008 年至 2016 年,我院共转运 222 例接受 ECMO 支持的患者。转运高峰和非转运高峰患者的基线特征和疾病严重程度指数无差异。在 84 例转运高峰患者中,59 例(70%)存活至出院,而非转运高峰患者 86 例(63%)(p=0.31)。多变量逻辑回归显示,年龄和急性生理学和慢性健康评估(APACHE)II 严重程度指数评分是院内死亡的预测因素(p<0.05),但转运高峰并非如此(比值比,0.91;95%置信区间,0.46 至 1.80;p=0.79)。
如果 ECMO 项目制定了处理临时增加量的计划,并考虑到工作人员的疲劳和倦怠,那么在 ECMO 转运量激增期间可以保持患者安全和临床结局。标准化医院间的沟通、患者选择和管理方案对于维持护理质量至关重要。